Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD.

AQP4-IgG neuromyelitis optica spectrum disorder MOG-IgG-associated disorders autoimmunity humoral immunity systemic lupus erythematous

Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 8 7 2020
medline: 25 9 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Aquaporin-4 (AQP4) neuromyelitis optica spectrum disorder (NMOSD) has been demonstrated to be associated with non-organ and organ-specific autoantibodies (antinuclear antibody, extractable nuclear antibody, double-stranded DNA, muscle acetylcholine receptor antibody) and systemic autoimmune diseases. In this study, we evaluated whether a similar association with non-organ and organ-specifc autoantibodies occurs in patients with MOG-IgG1-associated disorders. We determined that MOG-IgG1 was not strongly associated with these organ and non-organ-specific autoantibodies. Systemic lupus erythematous (SLE) was significantly associated with AQP4-IgG+ NMOSD and not with MOGAD (

Identifiants

pubmed: 32633603
doi: 10.1177/1352458520933884
doi:

Substances chimiques

Aquaporin 4 0
Autoantibodies 0
Immunoglobulin G 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

630-635

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002377
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS113828
Pays : United States

Auteurs

Amy Kunchok (A)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Eoin P Flanagan (EP)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Melissa Snyder (M)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Ruba Saadeh (R)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

John J Chen (JJ)

Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA/Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.

Brian G Weinshenker (BG)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Andrew McKeon (A)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Sean J Pittock (SJ)

Department of Neurology, Mayo Clinic, Rochester, MN, USA/Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH